Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00468338 · ClinicalTrials.gov registry record

Correlation BIS Scores Mentally Retarded Patients

A clinical trial, sponsored by Rutgers, The State University of New Jersey.

Completed
Registry status
90
Enrollment target

NCT00468338: Completed study, sponsored by Rutgers, The State University of New Jersey.

NCT00468338 is a clinical trial that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 90 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00468338 has completed, sponsored by Rutgers, The State University of New Jersey.

COMPLETED
Registry status
90 participants
Enrollment target

Study Summary

The BIS monitor is a tool which assists anesthesiologists in monitoring the depth of anesthesia or level of anesthesia. The study doctors would like to see if it is useful tool for patients who are mentally challenged and require anesthesia.

Interventions

  • DEVICE BIS monitor

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2006-12
Est. Completion 2008-05

What the finished NCT00468338 record still lists

NCT00468338 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 90 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which BIS monitor is the first listed.

NCT00468338 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00468338 about?

NCT00468338 is a clinical study titled "Correlation BIS Scores Mentally Retarded Patients". The BIS monitor is a tool which assists anesthesiologists in monitoring the depth of anesthesia or level of anesthesia. The study doctors would like to see if it is useful tool for patients who are mentally challenged and require anesthesia.

What is the current status of trial NCT00468338?

This trial is currently completed. The enrollment target is 90 participants. The study started on 2006-12. Estimated completion is 2008-05.

What interventions are being tested in trial NCT00468338?

The interventions under investigation include: BIS monitor (DEVICE).

Who is sponsoring clinical trial NCT00468338?

This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02521311 · 90 participants · Phase 2

    Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)

  • NCT02939573 · 90 participants · Phase 2

    A Randomized Multicenter Study for Isolated Skin Vasculitis

  • NCT03128879 · 90 participants · Phase 2

    Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL

  • NCT03184038 · 90 participants · NA

    Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00468338, the US trial registry maintained by the National Library of Medicine. NCT00468338 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.